PGMP for Alberta Surgical Patients
Launched by UNIVERSITY OF CALGARY · Aug 31, 2021
Trial Information
Current as of September 12, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is testing a new hospital program called the Perioperative Glycemic Management Pathway (PGMP). The idea is to better control blood sugar before, during, and after surgery to reduce problems that can come from high blood sugar after surgery. Researchers want to know if PGMP can shorten hospital stays, lower the chance of being readmitted within 30 days, reduce surgical site infections, and lower death rates within 30 days and one year. They’ll also look at whether this approach saves money for the health system. The program will be rolled out in several hospital departments across Alberta using a stepped-wedge plan, meaning some sites start with usual care and then switch to PGMP over time.
Who can be eligible: adults 18 and older who are having surgery and are expected to stay in the hospital for more than 24 hours after the operation. Participation is by invitation at the participating sites. The PGMP uses a blood test (HbA1c) to find people at higher risk for postoperative high blood sugar, then closely monitors glucose after surgery with quick tests and follows standardized care plans to manage it. If you’re invited and you participate, you’ll receive the PGMP care at your site during the study period, while other sites may continue with usual care. This is a pathway-of-care study (not a drug trial) conducted in Alberta, with ongoing enrollment and a target completion in 2025.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing a surgical procedure, adults (older than 18 years of age), admitted to the hospital for more than 24 hours after their surgical procedure.
- Exclusion Criteria:
- • Under 18 years of age
About University Of Calgary
The University of Calgary is a leading research institution dedicated to advancing health and science through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university's clinical research initiatives aim to address pressing health challenges and improve patient outcomes. The institution fosters a robust environment for academic inquiry, leveraging state-of-the-art facilities and a diverse network of experts in various fields. Committed to ethical research practices and community engagement, the University of Calgary strives to translate scientific discoveries into tangible benefits for society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Red Deer, Alberta, Canada
Calgary, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials